UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma

Emily S. Reardon(National Institutes of Health), David S. Schrump(National Institutes of Health), Markku Miettinen(National Institutes of Health), Raffit Hassan(National Cancer Institute), Liqiang Xi(Center for Cancer Research), Assunta De Rienzo(Brigham and Women's Hospital), William G. Richards(Brigham and Women's Hospital), Raphael Bueno(Brigham and Women's Hospital), Anju Kumari(Thoracic Surgery Foundation), Julie A. Hong(National Institutes of Health), Lisa Uechi(University of California, Los Angeles), Eden C. Payabyab(National Institutes of Health), David M. Straughan(National Institutes of Health), Mary Zhang(National Institutes of Health), Chuong D. Hoang(National Institutes of Health), Yi Liu(WinnMed), Xinmin Li(First Affiliated Hospital of Xinxiang Medical University), Haobin Chen(Washington University in St. Louis), Ruihong Wang(National Institutes of Health), Vivek Shukla(National Institutes of Health), Sudheer Kumar Gara(National Cancer Center), Sichuan Xi(National Cancer Center), Mark Raffeld(National Cancer Institute)
Journal of Thoracic Oncology
September 11, 2020
Cited by 38


Related Papers